PROTEOMICS PROFILING OF BREAST CANCER PATIENTS RECEIVING TAMOXIFEN

被引：0
|
作者：
Johansson, H. J. [2 ]
Sanchez, B. Chavez [1 ]
Bergh, J. [3 ,4 ,5 ]
Linderholm, B.
Lehtio, J.
机构：
[1] Karolinska Inst, Dept Oncol Pathol, KBC, Stockholm, Sweden
[2] Univ Hosp, KBC, Stockholm, Sweden
[3] Karolinska Hosp, Clin & Translat Res, S-10401 Stockholm, Sweden
[4] Univ Manchester, Manchester, Lancs, England
[5] Christie Med Oncol Breast Unit, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
70P
引用
收藏
页码：41 / 41
页数：1
相关论文
共 50 条
  • [1] Ovarian histopathology in breast cancer patients receiving tamoxifen
    McGonigle, KF
    Vasilev, SA
    Odom-Maryon, T
    Simpson, JF
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 73 (03) : 402 - 406
  • [2] ENDOMETRIAL CHANGES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS RECEIVING TAMOXIFEN
    LAHTI, E
    BLANCO, G
    KAUPPILA, A
    APAJASARKKINEN, M
    TASKINEN, PJ
    LAATIKAINEN, T
    [J]. OBSTETRICS AND GYNECOLOGY, 1993, 81 (05): : 660 - 664
  • [3] Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen
    Bese, T
    Kosebay, D
    Demirkiran, F
    Arvas, M
    Bese, N
    Mandel, N
    [J]. EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1996, 67 (02): : 157 - 162
  • [4] Plasma proteomics analysis of tamoxifen resistance in breast cancer
    Keivan Majidzadeh-A
    Javad Gharechahi
    [J]. Medical Oncology, 2013, 30
  • [5] Plasma proteomics analysis of tamoxifen resistance in breast cancer
    Majidzadeh-A, Keivan
    Gharechahi, Javad
    [J]. MEDICAL ONCOLOGY, 2013, 30 (04)
  • [6] Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
    Dijkhuizen, FPHLJ
    Brolmann, HAM
    Oddens, BJJ
    Roumen, RMH
    Coebergh, JWW
    Heintz, APM
    [J]. MATURITAS, 1996, 25 (01) : 45 - 50
  • [7] Screening for endometrial cancer in the patient receiving tamoxifen for breast cancer
    Barakat, RR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) : 1967 - 1968
  • [8] Expression profiling of breast cancer patients treated with tamoxifen: prognostic or predictive significance
    Sanaz Tabarestani
    Sayyed Mohammad Hossein Ghaderian
    Hamid Rezvani
    Reza Mirfakhraie
    [J]. Medical Oncology, 2014, 31
  • [9] Expression profiling of breast cancer patients treated with tamoxifen: prognostic or predictive significance
    Tabarestani, Sanaz
    Ghaderian, Sayyed Mohammad Hossein
    Rezvani, Hamid
    Mirfakhraie, Reza
    [J]. MEDICAL ONCOLOGY, 2014, 31 (04)
  • [10] Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer
    Henrik J Johansson
    Betzabe C Sanchez
    Jenny Forshed
    Olle Stål
    Helena Fohlin
    Rolf Lewensohn
    Per Hall
    Jonas Bergh
    Janne Lehtiö
    Barbro K Linderholm
    [J]. Clinical Proteomics, 2015, 12
12345